Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia

ClinicalTrials.gov ID: NCT01972178

Public ClinicalTrials.gov record NCT01972178. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 10:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is * To evaluate the efficacy of PRC-4016 by assessment of the percentage change in blood lipids and lipoprotein parameter from baseline after 12 weeks of treatment * To evaluate the safety of PRC-4016 as assessed by adverse events and other safety parameters

Study identification

NCT ID
NCT01972178
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pronova BioPharma
Industry
Enrollment
113 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 79 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2013 (Type not available)
Primary completion
Jul 2014 (Actual)
Completion
Aug 2014 (Actual)
Last update posted
Oct 30, 2015

2013 – 2014

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
Medical Affiliated Research Center, Inc. Huntsville Alabama 35801 —
Terence Hart, MD Muscle Shoals Alabama 35662 —
Pacific Oaks Medical Group Beverly Hills California 90211 —
National Research Institute - Wilshire Los Angeles California 90057 —
Research Across America - Santa Ana Santa Ana California 92705 —
Encompass Clinical Research Spring Valley California 91978 —
Jacksonville Impotence Treatment Center Jacksonville Florida 32223 —
Compass Research East, LLC Oviedo Florida 32765 —
Progressive Medical Research Port Orange Florida 32127 —
Meridien Research St. Petersburg Florida 33709 —
Meridien Research- Tampa Tampa Florida 33606 —
Evanston Premier Healthcare Research LLC Evanston Illinois 60201 —
Medisphere Medical Research Center Evansville Indiana 47714 —
Heartland Research Assoc., LLC Newton Kansas 67114 —
Louisville Metabolic and Atherosclerosis Research Center (L-MARC) Louisville Kentucky 40213 —
Troy Internal Medicine, P.C. Troy Michigan 48098 —
Radiant Research - Edina Edina Minnesota 55435 —
Peters Medical Research High Point North Carolina 27262 —
PMG Research of Raleigh, LLC Raleigh North Carolina 27609 —
Sterling Research Group, Ltd. - Auburn Cincinnati Ohio 45219 —
Metabolic and Atherosclerosis Research Center Cincinnati Ohio 45227 —
Columbus Clinical Research, Inc. Columbus Ohio 43213 —
PSB Research/P. S. Bains, M.S., D.O. Marion Ohio 43302 —
RAS Health Ltd Marion Ohio 43302 —
Willamette Valley Clinical Studies Eugene Oregon 97404 —
Green and Seidner Family Practice Associates Lansdale Pennsylvania 19446 —
Padre Coast Clinical Research Corpus Christi Texas 78404 —
National Clinical Research - Norfolk, Inc. Norfolk Virginia 23502 —
National Clinical Research - Richmond, Inc. Richmond Virginia 23294 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01972178, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 30, 2015 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01972178 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →